Mary Ellen Simcox
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cutaneous Melanoma Detection and Management
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Melanoma and MAPK Pathways 2
- DNA and Nucleic Acid Chemistry 2
- Advanced biosensing and bioanalysis techniques 2
- RNA modifications and cancer 2
- Oncology 5
- Cytokine Signaling Pathways and Interactions 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Kathleen Schostack (4 shared papers)Kenneth Kolinsky (4 shared papers)Brian Higgins (4 shared papers)Hong Yang (2 shared papers)Gideon Bollag (2 shared papers)David Heimbrook (2 shared papers)Fei Su (2 shared papers)Kathryn Packman (3 shared papers)
- Journals
- Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Clinical Cancer Research (2 papers)Gene (2 papers)Bioorganic & Medicinal Chemistry (1 paper)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Mary Ellen Simcox
12 papers receiving 629 citations
Peers
Comparison fields: 5 of 58
- Oncology 289
- Cancer Research 98
- Molecular Biology 421
- Pathology and Forensic Medicine 87
- Computational Theory and Mathematics 83
Countries citing papers authored by Mary Ellen Simcox
This map shows the geographic impact of Mary Ellen Simcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Simcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Simcox more than expected).
Fields of papers citing papers by Mary Ellen Simcox
This network shows the impact of papers produced by Mary Ellen Simcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Simcox. The network helps show where Mary Ellen Simcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Ellen Simcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 308 | |
| 2 | 2011 | 171 | |
| 3 | 2004 | 41 | |
| 4 | 2014 | 33 | |
| 5 | 2003 | 26 | |
| 6 | 2015 | 18 | |
| 7 | 2005 | 17 | |
| 8 | 2012 | 14 | |
| 9 | 1991 | 7 | |
| 10 | 1995 | 6 | |
| 11 | 2010 | 5 | |
| 12 | 2004 | 3 |
About Mary Ellen Simcox
Mary Ellen Simcox is a scholar working on Molecular Biology, Oncology, Cancer Research, Organic Chemistry and Genetics, having authored 12 papers that have together received 649 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), NF-κB Signaling Pathways (2 papers), Melanoma and MAPK Pathways (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), RNA modifications and cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (289 citations), Cancer Research (98 citations), Molecular Biology (421 citations), Pathology and Forensic Medicine (87 citations) and Computational Theory and Mathematics (83 citations). Mary Ellen Simcox has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Kathleen Schostack, Kenneth Kolinsky, Brian Higgins, Hong Yang, Gideon Bollag, David Heimbrook, Fei Su, Kathryn Packman, Sylvia Zhao and Zenaida Go. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, Clinical Cancer Research, Gene and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.